174 related articles for article (PubMed ID: 12195351)
21. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia.
Lundgren B; Lundgren JD; Nielsen T; Mathiesen L; Nielsen JO; Kovacs JA
J Infect Dis; 1992 Jun; 165(6):1151-5. PubMed ID: 1583338
[TBL] [Abstract][Full Text] [Related]
22. Immunological characterization of surface subtilisin-like protease (SSP) of Pneumocystis carinii.
Wada M; Nakamura Y
J Eukaryot Microbiol; 1999; 46(5):151S-152S. PubMed ID: 10519297
[No Abstract] [Full Text] [Related]
23. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
Bishop LR; Helman D; Kovacs JA
BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
[TBL] [Abstract][Full Text] [Related]
24. Antigenic variation in pneumocystis.
Stringer JR
J Eukaryot Microbiol; 2007; 54(1):8-13. PubMed ID: 17300510
[TBL] [Abstract][Full Text] [Related]
25. [Construction and expression of prokaryotic expression plasmids of Pneumocystis carinii p55 antigen gene fragment].
Wang JX; Duan YN; Chen JL; Dong YS
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):328-32. PubMed ID: 18038806
[TBL] [Abstract][Full Text] [Related]
26. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
Nahimana A; Rabodonirina M; Zanetti G; Meneau I; Francioli P; Bille J; Hauser PM
J Infect Dis; 2003 Oct; 188(7):1017-23. PubMed ID: 14513422
[TBL] [Abstract][Full Text] [Related]
27. Production and characterization of monoclonal antibodies specific for the major surface glycoprotein of Pneumocystis carinii.
Linke MJ; Smulian AG; Yoshihara P; Walzer PD
J Eukaryot Microbiol; 1994; 41(5):99S-100S. PubMed ID: 7804293
[No Abstract] [Full Text] [Related]
28. Ambient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia.
Blount RJ; Djawe K; Daly KR; Jarlsberg LG; Fong S; Balmes J; Miller RF; Walzer PD; Huang L;
PLoS One; 2013; 8(11):e80795. PubMed ID: 24236202
[TBL] [Abstract][Full Text] [Related]
29. Antigenic variation by telomeric recombination of major-surface-glycoprotein genes of Pneumocystis carinii.
Wada M; Nakamura Y
J Eukaryot Microbiol; 1996; 43(5):8S. PubMed ID: 8822816
[No Abstract] [Full Text] [Related]
30. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection.
Koval CE; Gigliotti F; Nevins D; Demeter LM
Clin Infect Dis; 2002 Aug; 35(4):491-3. PubMed ID: 12145736
[TBL] [Abstract][Full Text] [Related]
31. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
Smulian AG; Sullivan DW; Theus SA
Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses against Pneumocystis jirovecii in health care workers over time.
Fong S; Daly KR; Tipirneni R; Jarlsberg LG; Djawe K; Koch JV; Swartzman A; Roth B; Walzer PD; Huang L
Emerg Infect Dis; 2013 Oct; 19(10):1612-9. PubMed ID: 24048016
[TBL] [Abstract][Full Text] [Related]
33. Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii.
Linke MJ; Sunkin SM; Andrews RP; Stringer JR; Walzer PD
Clin Diagn Lab Immunol; 1998 Jan; 5(1):50-7. PubMed ID: 9455880
[TBL] [Abstract][Full Text] [Related]
34. Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii.
Ma L; Kutty G; Jia Q; Imamichi H; Huang L; Atzori C; Beckers P; Groner G; Beard CB; Kovacs JA
J Infect Dis; 2002 Dec; 186(11):1647-54. PubMed ID: 12447742
[TBL] [Abstract][Full Text] [Related]
35. [Occurrence of Pneumocystis carinii DNA and anti-Pneumocystis antibodies in the sera of infants during a period of of physiologic decreased immune response].
Elzbieta G; Sobolewska A; Matysiak E
Wiad Parazytol; 2002; 48(3):287-92. PubMed ID: 16888974
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus
Schmid-Siegert E; Richard S; Luraschi A; Mühlethaler K; Pagni M; Hauser PM
mBio; 2017 Nov; 8(6):. PubMed ID: 29114024
[TBL] [Abstract][Full Text] [Related]
37. Pneumocystis carinii infection alters GTP-binding proteins in the lung.
Oz HS; Hughes WT
J Parasitol; 1997 Aug; 83(4):679-85. PubMed ID: 9267411
[TBL] [Abstract][Full Text] [Related]
38. Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians.
Nkinin SW; Daly KR; Walzer PD; Ndzi ES; Asonganyi T; Respaldiza N; Medrano FJ; Kaneshiro ES
Acta Trop; 2009 Nov; 112(2):219-24. PubMed ID: 19665440
[TBL] [Abstract][Full Text] [Related]
39. Establishment of rat model for Pneumocystis carinii infection and cloning of the surface glycoprotein A gene of Pneumocystis carinii.
Ouyang LS; Mo QY; Peng HJ; Chen XG; Shen SM
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):427-9. PubMed ID: 12390704
[TBL] [Abstract][Full Text] [Related]
40. Low levels of IgG antibodies against pneumocystis carinii among HIV-infected patients.
Laursen AL; Andersen PL
Scand J Infect Dis; 1998; 30(5):495-9. PubMed ID: 10066052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
